Welcome to Tip’d, a social media site for finance, investing, and business topics. Want to participate? » Join Tip’d now! or read our FAQ.
Hedge fund manager P. Schoenfeld Asset Management (PSAM) announced that it will be voting in favor of the slate of board of directors for Amylin Pharmaceuticals (AMLN) that has been nominated by activist hedge funds Icahn Associates and Eastbourne.
Save & Share
Spam? Topple this!
Save & Share
Spam? Topple this!
HedgeFundTracker
Comments
Want to leave a comment on this story? Login or join Tip'd to comment.